{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:31:51Z","timestamp":1785515511692,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,25]]},"DOI":"10.7759\/cureus.104238","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:28:25Z","timestamp":1772033305000},"source":"Crossref","is-referenced-by-count":2,"title":["Neonatal Sepsis: Pathogens, Clinical Challenges, and Emerging Solutions"],"prefix":"10.7759","author":[{"given":"Matthew","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Blavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-02202-9_61","article-title":"Bacterial sepsis and shock","author":"Alten J","year":"2012","unstructured":"Alten J, Prabhakaran P. Bacterial sepsis and shock. Textbook of Clinical Pediatrics. 2012, 783-9. 10.1007\/978-3-642-02202-9_61","journal-title":"Textbook of Clinical Pediatrics"},{"key":"ref2","article-title":"Systemic Inflammatory Response Syndrome","author":"Chakraborty RK","year":"2025","unstructured":"Chakraborty RK, Basu B. Systemic Inflammatory Response Syndrome. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.05.048","article-title":"Neonatal sepsis of early onset, and hospital community-acquired late onset: a prospective population-based cohort study","volume":"201","author":"Giannoni E","year":"2018","unstructured":"Giannoni E, Agyeman PK, Stocker M, et al.. Neonatal sepsis of early onset, and hospital community-acquired late onset: a prospective population-based cohort study. J Pediatr. 2018, 201:106-114.e4. 10.1016\/j.jpeds.2018.05.048","journal-title":"J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.30476\/IJMS.2022.92284.2352","article-title":"Clinical risk factors for early-onset sepsis in neonates: an international Delphi study","volume":"48","author":"Moftian N","year":"2023","unstructured":"Moftian N, Samad Soltani T, Mirnia K, Esfandiari A, Tabib MS, Rezaei Hachesu P. Clinical risk factors for early-onset sepsis in neonates: an international Delphi study. Iran J Med Sci. 2023, 48:57-69. 10.30476\/IJMS.2022.92284.2352","journal-title":"Iran J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.23937\/2469-5769\/1510088","article-title":"Perinatal risk factors and early onset of neonatal sepsis","volume":"8","author":"Noah FN","year":"2022","unstructured":"Noah FN, Diallo L, Jouni O. Perinatal risk factors and early onset of neonatal sepsis. Int J Pediatr. 2022, 8:1510088. 10.23937\/2469-5769\/1510088","journal-title":"Int J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1393936","article-title":"Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at <32 weeks' gestation","volume":"32","author":"Shah J","year":"2015","unstructured":"Shah J, Jefferies AL, Yoon EW, Lee SK, Shah PS. Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at &lt;32 weeks' gestation. Am J Perinatol. 2015, 32:675-82. 10.1055\/s-0034-1393936","journal-title":"Am J Perinatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40124-023-00305-3","article-title":"The aetiology and global impact of paediatric sepsis","volume":"11","author":"Bracken A","year":"2023","unstructured":"Bracken A, Lenihan R, Khanijau A, Carrol ED. The aetiology and global impact of paediatric sepsis. Curr Pediatr Rep. 2023, 11:204-13. 10.1007\/s40124-023-00305-3","journal-title":"Curr Pediatr Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13049-019-0596-4","article-title":"Sepsis: mechanisms of bacterial injury to the patient","volume":"27","author":"Minasyan H","year":"2019","unstructured":"Minasyan H. Sepsis: mechanisms of bacterial injury to the patient. Scand J Trauma Resusc Emerg Med. 2019, 27:19. 10.1186\/s13049-019-0596-4","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018, 392:1789-858. 10.1016\/S0140-6736(18)32279-7","journal-title":"Lancet"},{"key":"ref10","unstructured":"Neonatal sepsis and other neonatal infections\u2014Level 4 cause. (2021). Accessed. 2025: https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-neonatal-sepsis-and-other-neonatal."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004485","article-title":"Beyond early- and late-onset neonatal sepsis definitions: what are the current causes of neonatal sepsis globally? A systematic review and meta-analysis of the evidence","volume":"43","author":"Harrison ML","year":"2024","unstructured":"Harrison ML, Dickson BF, Sharland M, Williams PC. Beyond early- and late-onset neonatal sepsis definitions: what are the current causes of neonatal sepsis globally? A systematic review and meta-analysis of the evidence. Pediatr Infect Dis J. 2024, 43:1182-90. 10.1097\/INF.0000000000004485","journal-title":"Pediatr Infect Dis J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004179","article-title":"Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: a global neonatal sepsis observational cohort study (NeoOBS)","volume":"20","author":"Russell NJ","year":"2023","unstructured":"Russell NJ, St\u00f6hr W, Plakkal N, et al.. Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: a global neonatal sepsis observational cohort study (NeoOBS). PLoS Med. 2023, 20:e1004179. 10.1371\/journal.pmed.1004179","journal-title":"PLoS Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00195-3","article-title":"Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"22","author":"GBD 2019 Meningitis Antimicrobial Resistance Collaborators","year":"2023","unstructured":"GBD 2019 Meningitis Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023, 22:685-711. 10.1016\/S1474-4422(23)00195-3","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","article-title":"Group B Streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe VN","year":"2019","unstructured":"Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019, 7:10.1128\/microbiolspec.GPP3-0007-2018","journal-title":"Microbiol Spectr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/C2009-0-50442-4","article-title":"Infectious Diseases of the Fetus and Newborn Infant","year":"2011","unstructured":"Infectious Diseases of the Fetus and Newborn Infant. Remington JS, Klein JO, Maldonado Y, Nizet V (ed). Saunders, Philadelphia, PA; 2011. 10.1016\/C2009-0-50442-4"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-2217","article-title":"Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues","volume":"127","author":"Stoll BJ","year":"2011","unstructured":"Stoll BJ, Hansen NI, S\u00e1nchez PJ, et al.. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011, 127:817-26. 10.1542\/peds.2010-2217","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122753","article-title":"A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta","volume":"210","author":"Whidbey C","year":"2013","unstructured":"Whidbey C, Harrell MI, Burnside K, et al.. A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J Exp Med. 2013, 210:1265-81. 10.1084\/jem.20122753","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2741\/1296","article-title":"Extracellular virulence factors of group B Streptococci","volume":"9","author":"Liu GY","year":"2004","unstructured":"Liu GY, Nizet V. Extracellular virulence factors of group B Streptococci. Front Biosci. 2004, 9:1794-802. 10.2741\/1296","journal-title":"Front Biosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.11.001","article-title":"Group B Streptococcus evades host immunity by degrading hyaluronan","volume":"18","author":"Kolar SL","year":"2015","unstructured":"Kolar SL, Kyme P, Tseng CW, et al.. Group B Streptococcus evades host immunity by degrading hyaluronan. Cell Host Microbe. 2015, 18:694-704. 10.1016\/j.chom.2015.11.001","journal-title":"Cell Host Microbe"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-13","article-title":"Early-onset neonatal sepsis","volume":"27","author":"Simonsen KA","year":"2014","unstructured":"Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014, 27:21-47. 10.1128\/CMR.00031-13","journal-title":"Clin Microbiol Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9363.1","article-title":"Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries","volume":"5","author":"Kobayashi M","year":"2016","unstructured":"Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res. 2016, 5:2355. 10.12688\/f1000research.9363.1","journal-title":"F1000Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16085","article-title":"Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis","volume":"127","author":"Hasperhoven GF","year":"2020","unstructured":"Hasperhoven GF, Al-Nasiry S, Bekker V, Villamor E, Kramer B. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis. BJOG. 2020, 127:680-91. 10.1111\/1471-0528.16085","journal-title":"BJOG"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10101878","article-title":"Escherichia coli is overtaking group B Streptococcus in early-onset neonatal sepsis","volume":"10","author":"Miselli F","year":"2022","unstructured":"Miselli F, Cuoghi Costantini R, Creti R, et al.. Escherichia coli is overtaking group B Streptococcus in early-onset neonatal sepsis. Microorganisms. 2022, 10:1878. 10.3390\/microorganisms10101878","journal-title":"Microorganisms"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03659-8","article-title":"Neonatal and young infant sepsis by group B streptococci and Escherichia coli: a single-center retrospective analysis in Germany-GBS screening implementation gaps and reduction in antibiotic resistance","volume":"179","author":"Doenhardt M","year":"2020","unstructured":"Doenhardt M, Seipolt B, Mense L, et al.. Neonatal and young infant sepsis by group B streptococci and Escherichia coli: a single-center retrospective analysis in Germany-GBS screening implementation gaps and reduction in antibiotic resistance. Eur J Pediatr. 2020, 179:1769-77. 10.1007\/s00431-020-03659-8","journal-title":"Eur J Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.5.1929-1935.2003","article-title":"Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors","volume":"41","author":"Watt S","year":"2003","unstructured":"Watt S, Lanotte P, Mereghetti L, Moulin-Schouleur M, Picard B, Quentin R. Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors. J Clin Microbiol. 2003, 41:1929-35. 10.1128\/JCM.41.5.1929-1935.2003","journal-title":"J Clin Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.0593","article-title":"Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies","volume":"174","author":"Stoll BJ","year":"2020","unstructured":"Stoll BJ, Puopolo KM, Hansen NI, et al.. Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 2020, 174:e200593. 10.1001\/jamapediatrics.2020.0593","journal-title":"JAMA Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0014-2018","article-title":"Epidemiology and clinical manifestations of Listeria monocytogenes infection","volume":"7","author":"Schlech WF","year":"2019","unstructured":"Schlech WF. Epidemiology and clinical manifestations of Listeria monocytogenes infection. Microbiol Spectr. 2019, 7:10.1128\/microbiolspec.GPP3-0014-2018","journal-title":"Microbiol Spectr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341206","article-title":"Intracellular pathogenesis of listeriosis","volume":"334","author":"Southwick FS","year":"1996","unstructured":"Southwick FS, Purich DL. Intracellular pathogenesis of listeriosis. N Engl J Med. 1996, 334:770-6. 10.1056\/NEJM199603213341206","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401434101","article-title":"Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin","volume":"101","author":"Lecuit M","year":"2004","unstructured":"Lecuit M, Nelson DM, Smith SD, et al.. Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin. Proc Natl Acad Sci U S A. 2004, 101:6152-7. 10.1073\/pnas.0401434101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/608456","article-title":"Role of pore-forming toxins in neonatal sepsis","volume":"2013","author":"Sonnen AF","year":"2013","unstructured":"Sonnen AF, Henneke P. Role of pore-forming toxins in neonatal sepsis. Clin Dev Immunol. 2013, 2013:608456. 10.1155\/2013\/608456","journal-title":"Clin Dev Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/82_2016_30","article-title":"ActA of Listeria monocytogenes and its manifold activities as an important listerial virulence factor","volume":"399","author":"Pillich H","year":"2017","unstructured":"Pillich H, Puri M, Chakraborty T. ActA of Listeria monocytogenes and its manifold activities as an important listerial virulence factor. Curr Top Microbiol Immunol. 2017, 399:113-32. 10.1007\/82_2016_30","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221117207","article-title":"Clinical features and antibiotic treatment of early-onset neonatal listeriosis","volume":"50","author":"Wu F","year":"2022","unstructured":"Wu F, Nizar S, Zhang L, Wang F, Lin X, Zhou X. Clinical features and antibiotic treatment of early-onset neonatal listeriosis. J Int Med Res. 2022, 50:3000605221117207. 10.1177\/03000605221117207","journal-title":"J Int Med Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000457501.73326.6c","article-title":"Committee opinion no. 614: management of pregnant women with presumptive exposure to Listeria monocytogenes","volume":"124","year":"2014","unstructured":"Committee opinion no. 614. management of pregnant women with presumptive exposure to Listeria monocytogenes. Obstet Gynecol. 2014, 124:1241-4. 10.1097\/01.AOG.0000457501.73326.6c","journal-title":"Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-022-01440-3","article-title":"Neonatal Staphylococcus aureus sepsis: a 20-year Western Australian experience","volume":"42","author":"Shadbolt R","year":"2022","unstructured":"Shadbolt R, We ML, Kohan R, et al.. Neonatal Staphylococcus aureus sepsis: a 20-year Western Australian experience. J Perinatol. 2022, 42:1440-5. 10.1038\/s41372-022-01440-3","journal-title":"J Perinatol"},{"key":"ref35","unstructured":"Neonatal sepsis and other infections. (2014). Accessed. 2025: https:\/\/www.utmb.edu\/pedi_ed\/NeonatologyManual\/InfectiousDiseases\/mobile_pages\/InfectiousDiseases2.html."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmu079","article-title":"Challenges in the diagnosis and management of neonatal sepsis","volume":"61","author":"Zea-Vera A","year":"2015","unstructured":"Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015, 61:1-13. 10.1093\/tropej\/fmu079","journal-title":"J Trop Pediatr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2024.59","article-title":"Staphylococcal aureus outbreaks in neonatal intensive care units: strategies, nuances, and lessons learned from the frontline","volume":"4","author":"Rooney CM","year":"2024","unstructured":"Rooney CM, Lancaster R, McKechnie L, Sethi K. Staphylococcal aureus outbreaks in neonatal intensive care units: strategies, nuances, and lessons learned from the frontline. Antimicrob Steward Healthc Epidemiol. 2024, 4:e70. 10.1017\/ash.2024.59","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70870-9","article-title":"The global burden of listeriosis: a systematic review and meta-analysis","volume":"14","author":"de Noordhout CM","year":"2014","unstructured":"de Noordhout CM, Devleesschauwer B, Angulo FJ, et al.. The global burden of listeriosis: a systematic review and meta-analysis. Lancet Infect Dis. 2014, 14:1073-82. 10.1016\/S1473-3099(14)70870-9","journal-title":"Lancet Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.4719","article-title":"Antibiotic susceptibility of Escherichia coli among infants admitted to neonatal intensive care units across the US from 2009 to 2017","volume":"175","author":"Flannery DD","year":"2021","unstructured":"Flannery DD, Akinboyo IC, Mukhopadhyay S, et al.. Antibiotic susceptibility of Escherichia coli among infants admitted to neonatal intensive care units across the US from 2009 to 2017. JAMA Pediatr. 2021, 175:168-75. 10.1001\/jamapediatrics.2020.4719","journal-title":"JAMA Pediatr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000361.pub4","article-title":"Intravenous immunoglobulin for preventing infection in preterm and\/or low birth weight infants","volume":"1","author":"Ohlsson A","year":"2020","unstructured":"Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2020, 1:CD000361. 10.1002\/14651858.CD000361.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003066","article-title":"G-CSF and GM-CSF for treating or preventing neonatal infections","volume":"2003","author":"Carr R","year":"2003","unstructured":"Carr R, Modi N, Dor\u00e9 C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev. 2003, 2003:CD003066. 10.1002\/14651858.CD003066","journal-title":"Cochrane Database Syst Rev"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3329\/jbcps.v24i3.158","article-title":"Role of intravenous immunoglobulin (IVIG) as an adjuvant in the treatment of neonatal sepsis in preterm babies","volume":"24","author":"Ahmed SS","year":"2006","unstructured":"Ahmed SS, Chowdhury MAKA, Hoque MM, Begum D, Ahmed A. Role of intravenous immunoglobulin (IVIG) as an adjuvant in the treatment of neonatal sepsis in preterm babies. J Bangladesh Coll Physicians Surg. 2006, 24:97-104. 10.3329\/jbcps.v24i3.158","journal-title":"J Bangladesh Coll Physicians Surg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5143-7","article-title":"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)","volume":"44","author":"Welte T","year":"2018","unstructured":"Welte T, Dellinger RP, Ebelt H, et al.. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med. 2018, 44:438-48. 10.1007\/s00134-018-5143-7","journal-title":"Intensive Care Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group B Streptococcus","volume":"389","author":"Madhi SA","year":"2023","unstructured":"Madhi SA, Anderson AS, Absalon J, et al.. Potential for maternally administered vaccine for infant group B Streptococcus. N Engl J Med. 2023, 389:215-27. 10.1056\/NEJMoa2116045","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2017.11.008","article-title":"Probiotics and necrotizing enterocolitis","volume":"27","author":"Patel RM","year":"2018","unstructured":"Patel RM, Underwood MA. Probiotics and necrotizing enterocolitis. Semin Pediatr Surg. 2018, 27:39-46. 10.1053\/j.sempedsurg.2017.11.008","journal-title":"Semin Pediatr Surg"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.122226.3","article-title":"Probiotic effect in preterm neonates with sepsis - a systematic review protocol","volume":"11","author":"Iqbal F","year":"2022","unstructured":"Iqbal F, Siva N, Kolibylu Raghupathy M, Edward S Lewis L, Barche A, Purkayastha J, S Nayak B. Probiotic effect in preterm neonates with sepsis - a systematic review protocol. F1000Res. 2022, 11:913. 10.12688\/f1000research.122226.3","journal-title":"F1000Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13195959","article-title":"AI algorithms for modeling the risk, progression, and treatment of sepsis, including early-onset sepsis\u2014a systematic review","volume":"13","author":"T\u0105del K","year":"2024","unstructured":"T\u0105del K, Dudek A, Bil-Lula I. AI algorithms for modeling the risk, progression, and treatment of sepsis, including early-onset sepsis\u2014a systematic review. J Clin Med. 2024, 13:5959. 10.3390\/jcm13195959","journal-title":"J Clin Med"},{"key":"ref48","unstructured":"N\/IICU clinical pathway for evaluation and treatment of suspected sepsis in newborns and infants. (2018). Accessed. 2025: https:\/\/www.chop.edu\/clinical-pathway\/sepsis-niicu-clinical-pathway."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2021-006058","article-title":"A clinical monitoring approach for early onset sepsis: a community hospital experience","volume":"12","author":"Bain L","year":"2022","unstructured":"Bain L, Sivakumar D, McCallie K, Balasundaram M, Frymoyer A. A clinical monitoring approach for early onset sepsis: a community hospital experience. Hosp Pediatr. 2022, 12:16-21. 10.1542\/hpeds.2021-006058","journal-title":"Hosp Pediatr"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.2825","article-title":"Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis","volume":"173","author":"Achten NB","year":"2019","unstructured":"Achten NB, Klingenberg C, Benitz WE, et al.. Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis. JAMA Pediatr. 2019, 173:1032-40. 10.1001\/jamapediatrics.2019.2825","journal-title":"JAMA Pediatr"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-019-02870-2","article-title":"Integrated management of newborn and childhood illness (IMNCI) strategy and its implementation in real life situation","volume":"86","author":"Aneja S","year":"2019","unstructured":"Aneja S. Integrated management of newborn and childhood illness (IMNCI) strategy and its implementation in real life situation. Indian J Pediatr. 2019, 86:622-7. 10.1007\/s12098-019-02870-2","journal-title":"Indian J Pediatr"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-06820-5","article-title":"Early onset neonatal sepsis and its associatited factors: a cross sectional study","volume":"24","author":"Lemma K","year":"2024","unstructured":"Lemma K, Berhane Y. Early onset neonatal sepsis and its associatited factors: a cross sectional study. BMC Pregnancy Childbirth. 2024, 24:617. 10.1186\/s12884-024-06820-5","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2006.00980.x","article-title":"Incubation time required for neonatal blood cultures to become positive","volume":"42","author":"Jardine L","year":"2006","unstructured":"Jardine L, Davies MW, Faoagali J. Incubation time required for neonatal blood cultures to become positive. J Paediatr Child Health. 2006, 42:797-802. 10.1111\/j.1440-1754.2006.00980.x","journal-title":"J Paediatr Child Health"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02237-07","article-title":"Gram stain-specific-probe-based real-time PCR for diagnosis and discrimination of bacterial neonatal sepsis","volume":"46","author":"Wu YD","year":"2008","unstructured":"Wu YD, Chen LH, Wu XJ, Shang SQ, Lou JT, Du LZ, Zhao ZY. Gram stain-specific-probe-based real-time PCR for diagnosis and discrimination of bacterial neonatal sepsis. J Clin Microbiol. 2008, 46:2613-9. 10.1128\/JCM.02237-07","journal-title":"J Clin Microbiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S487757","article-title":"Pathogen distribution of neonatal bacterial meningitis in the era of multidrug-resistant bacteria: a single-center experience","volume":"17","author":"Zhu M","year":"2024","unstructured":"Zhu M, Lin J, Zhuge Z, et al.. Pathogen distribution of neonatal bacterial meningitis in the era of multidrug-resistant bacteria: a single-center experience. Infect Drug Resist. 2024, 17:5277-86. 10.2147\/IDR.S487757","journal-title":"Infect Drug Resist"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00031","article-title":"Etiology and clinical features of full-term neonatal bacterial meningitis: a multicenter retrospective cohort study","volume":"7","author":"Xu M","year":"2019","unstructured":"Xu M, Hu L, Huang H, et al.. Etiology and clinical features of full-term neonatal bacterial meningitis: a multicenter retrospective cohort study. Front Pediatr. 2019, 7:31. 10.3389\/fped.2019.00031","journal-title":"Front Pediatr"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-022-00266-4","article-title":"Incidence and risk factors of urinary tract infection in neonatal sepsis","volume":"11","author":"Kamel AS","year":"2022","unstructured":"Kamel AS, Abd El Moktader AM, Abd El Reheem F, Sayed MA. Incidence and risk factors of urinary tract infection in neonatal sepsis. Beni-Suef Univ J Basic Appl Sci. 2022, 11:87. 10.1186\/s43088-022-00266-4","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081233","article-title":"Biomarkers of neonatal sepsis: where we are and where we are going","volume":"12","author":"Boscarino G","year":"2023","unstructured":"Boscarino G, Migliorino R, Carbone G, et al.. Biomarkers of neonatal sepsis: where we are and where we are going. Antibiotics (Basel). 2023, 12:1233. 10.3390\/antibiotics12081233","journal-title":"Antibiotics (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052228","article-title":"Evaluation and management of well-appearing febrile infants 8 to 60 days old","volume":"148","author":"Pantell RH","year":"2021","unstructured":"Pantell RH, Roberts KB, Adams WG, et al.. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021, 148:e2021052228. 10.1542\/peds.2021-052228","journal-title":"Pediatrics"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03448-1","article-title":"Microbial cell-free DNA-sequencing as an addition to conventional diagnostics in neonatal sepsis","volume":"97","author":"Balks J","year":"2025","unstructured":"Balks J, Grumaz S, Mazzitelli S, et al.. Microbial cell-free DNA-sequencing as an addition to conventional diagnostics in neonatal sepsis. Pediatr Res. 2025, 97:614-24. 10.1038\/s41390-024-03448-1","journal-title":"Pediatr Res"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2019.05.003","article-title":"Next-generation sequencing in clinical microbiology: are we there yet?","volume":"39","author":"Mitchell SL","year":"2019","unstructured":"Mitchell SL, Simner PJ. Next-generation sequencing in clinical microbiology: are we there yet?. Clin Lab Med. 2019, 39:405-18. 10.1016\/j.cll.2019.05.003","journal-title":"Clin Lab Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-15-S2-S7","article-title":"Inpatient care of small and sick newborns: a multi-country analysis of health system bottlenecks and potential solutions","volume":"15 Suppl 2","author":"Moxon SG","year":"2015","unstructured":"Moxon SG, Lawn JE, Dickson KE, et al.. Inpatient care of small and sick newborns: a multi-country analysis of health system bottlenecks and potential solutions. BMC Pregnancy Childbirth. 2015, 15 Suppl 2:S7. 10.1186\/1471-2393-15-S2-S7","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397118-neonatal-sepsis-pathogens-clinical-challenges-and-emerging-solutions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:28:27Z","timestamp":1772033307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397118-neonatal-sepsis-pathogens-clinical-challenges-and-emerging-solutions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":62,"URL":"https:\/\/doi.org\/10.7759\/cureus.104238","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}